Sectra ABMIL:1SECT 78 EBITDA Margin % is 23.75% as of Apr. 2026, which is 0% above its 10-year median of 23.67. GuruFocus rates MIL:1SECT with a GF Score™ of 78/100 and a GF Value™ of €28.93 (Fairly Valued). Among 816 Medical Devices & Instruments companies, Sectra AB ranks better than 82.35% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sectra AB's EBITDA for the
three
months ended in Apr. 2026 was €22.6 Mil. Sectra AB's Revenue for the
three
months ended in Apr. 2026 was €95.3 Mil. Therefore, Sectra AB's EBITDA margin for the quarter that ended in Apr. 2026 was 23.75%.
Sectra AB (MIL:1SECT) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sectra AB EBITDA Margin % Related Terms
Sectra AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sectra AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SECT vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Sectra AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sectra AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (MIL:1SECT) has a EBITDA Margin % of 23.75% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sectra AB and its competitors. This is near median its historical median of 23.67. Over the past decade, Sectra AB's EBITDA Margin % has ranged from 21.00 to 26.28. According to the industry distribution chart, Sectra AB ranks #144 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 17.6%.
Is Sectra AB's EBITDA Margin % too high?
Sectra AB's current EBITDA Margin % of 23.75% is near median its 10-year median of 23.67. Over the past 10 years, this metric has ranged from a low of 21.00 to a high of 26.28. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Sectra AB's value of 23.75% is 217.7% above this industry median. Based on the distribution chart, Sectra AB ranks #144 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #144 out of 816 companies for EBITDA Margin %. This places Sectra AB in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Sectra AB's value of 23.75% is 217.7% above this benchmark. Historically, Sectra AB's own EBITDA Margin % has ranged from 21.00 to 26.28 over the past decade. While the company's 10-year median is 23.67 vs. the industry median of 7.48, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current EBITDA Margin % of 23.75% is 217.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current EBITDA Margin % is 23.75%, which is near median its own 10-year median of 23.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current EBITDA Margin % is 23.75%, which is near median its 10-year median of 23.67 and 217.7% above the Medical Devices & Instruments industry median of 7.48. Sectra AB's overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current EBITDA Margin % is 23.75% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
EBITDA Margin %: 23.75% (near median its 10-year median of 23.67)
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
Industry Position: 217.7% above the Medical Devices & Instruments median (#144 of 816)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
78GF Score
Get the complete analysis for MIL:1SECT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
